Dr. Khong on the Importance of BRCA Testing in Breast Cancer
Hung Khong, MD, underscores the importance of testing for BRCA mutations in patients with breast cancer.
Dr. Khong on the Potential Benefit of IO/Endocrine Therapy in ER+ Breast Cancer
Hung Khong, MD, discusses the potential benefit of combining immunotherapy with endocrine therapy in estrogen receptor–positive, HER2-negative breast cancer.
Dr. Khong on Endocrine Therapy Combinations in ER+/HER2- Breast Cancer
Hung Khong, MD, discusses antiestrogen and immunotherapy combinations in ER-positive, HER2-negative breast cancer.
Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast Cancers
Hung T. Khong, MD, medical oncologist, Moffitt Cancer Center, discusses the use of neoadjuvant endocrine therapy.
Resection and Reconstruction of a Solitary Sternal Metastasis After Mastectomy for Breast Cancer: A Case Report and Review of the Literature
In May 2005, a 25-year-old female presented to her primary care physician complaining of a newly palpable breast mass that had grown to several centimeters over the course of a few months.
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
Later-Line Ruxolitinib Use Produces Ongoing Benefit in Real-World Patients With cGVHD
Orca-T Data With Survival, Tolerability Extends to Older Patients With Hematologic Cancers
2 Commerce Drive Cranbury, NJ 08512